Larvol Delta - The-Institute-for-Molecular-Medicine-has-Received-a-Total-77M-From-NIH-to-Develop-a-FirstofitsKind-Vaccine-Targeting-Both-Hallmarks-of-Alzheimers-Disease

AV-1959R - Nuravax

https://www.prnewswire.com/news-releases/the-institute-for-molecular-medicine-has-received-a-total-7-7m-from-nih-to-develop-a-first-of-its-kind-vaccine-targeting-both-hallmarks-of-alzheimers-disease-301428835.html

Nov 22, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next